Related Experiment Video
Updated: Jun 1, 2026
07:52
Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
19.7K
Unveiling the Rarity: CD20 Expression in Mycosis Fungoides and Its Clinical Significance.
Nada Shaker1, Omar P Sangueza2
1Department of Pathology, The Ohio State University Wexner Medical Center/James Cancer Hospital, Columbus, OH; and.
The American Journal of Dermatopathology
|September 18, 2024
Summary
This study reports a rare case of CD20-positive mycosis fungoides (MF), a T-cell lymphoma. The findings highlight the need for further research into this unusual presentation and its clinical implications.
Area of Science:
- Dermatology
- Oncology
- Immunology
Background:
- Mycosis fungoides (MF) is a type of T-cell lymphoma.
- CD20 expression is typically rare in MF but common in other T-cell lymphomas.
Observation:
- A 30-year-old man presented with a hypopigmented patch on his chest.
- Histopathology showed epidermotropic infiltrates of lymphocytes.
- Immunophenotyping revealed neoplastic T cells with CD4+, CD8+, CD3+, and CD7- expression.
Findings:
- A subset of neoplastic T cells in this MF case expressed CD20.
- This is an infrequent observation in CD20-positive MF cases.
Implications:
- The significance of CD20 expression in MF is unclear, possibly indicating immune dysregulation or disease progression.
- Further research on CD20-positive MF is crucial for understanding clinical features, prognosis, and treatment.
- The long-term outcomes for hypopigmented MF with CD20 positivity require further investigation.
